KALARIS THERAPEUTICS, INC. Capitalized Computer Software, Amortization
KALARIS THERAPEUTICS, INC. (KLRS) reported Capitalized Computer Software, Amortization of $500.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2024-03-15
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2021-12-31 was $0.10.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2021-09-30 was $0.00.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2021-06-30 was $0.00.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2020-12-31 was $0.00.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for fiscal 2023 was $500.00K, a 0.00% change from fiscal 2022.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for fiscal 2022 was $500.00K, a 499999900.00% increase from fiscal 2021.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for fiscal 2021 was $0.10.
- KALARIS THERAPEUTICS, INC. capitalized computer software, amortization for fiscal 2020 was $0.00.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 12 month | Capitalized Computer Software, Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $500.00K 10-K · filed 2024-03-15 | ||||
| 2022-12-31 | $500.00K 10-K · filed 2024-03-15 | ||||
| 2021-12-31 | $0.10 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.10 derived: sum of 2 quarters · filed 2023-02-15 | $0.10 derived: sum of 3 quarters · filed 2023-02-15 | $0.10 10-K · filed 2023-02-15 | $100.00K 10-K · filed 2022-02-10 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-10 | $0.00 10-K · filed 2022-02-10 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |